Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
29 authors.
Naoto KuyamaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-5803-5324
Yasuhiro IzumiyaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0003-2332-9151
Seiji TakashioDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-6201-0701
Hiroki UsukuDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0003-4086-7541
Akihisa TabiraDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Hidekazu KondoDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.ORCID 0000-0003-2451-5845
Shotaro SaitoDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.ORCID 0009-0007-8809-2358
Keisuke YonezuDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.ORCID 0009-0008-0003-7715
Nozomi KodamaDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.ORCID 0009-0000-9355-4421
Takuto ZaizenDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.ORCID 0009-0007-4969-1622
Hirochika YamasakiDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.
Yosuke SuikoDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine University of Miyazaki Japan.ORCID 0009-0000-2188-5803
Miyuki OgataHeart Center, Faculty of Medicine University of Miyazaki Hospital Miyazaki Japan.ORCID 0009-0005-4402-5490
Yunosuke MatsuuraDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine University of Miyazaki Japan.ORCID 0000-0003-2927-7284
Toshihiro TsurudaDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine University of Miyazaki Japan.ORCID 0000-0002-9130-109X
Masanobu IshiiDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0003-4137-9136
Masahiro YamamotoDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-6994-040X
Kyoko HirakawaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-3598-0235
Hisanori KanazawaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0003-3925-2945
Tadashi HoshiyamaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-1315-5904
Masafumi KidohDepartment of Diagnostic Radiology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0002-9589-7054
Seitaro OdaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0003-4101-5113
Shinsuke HanataniDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0000-0001-9627-9373
Yasushi MatsuzawaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID 0009-0005-0346-4198
Eiichiro YamamotoDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Mitsuharu UedaDepartment of Neurology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Naohiko TakahashiDepartment of Cardiology and Clinical Examination, Faculty of Medicine Oita University Yufu Japan.
Koichi KaikitaDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine University of Miyazaki Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
backgroundLeft atrial functional parameters are established predictors of atrial fibrillation (AF), but the role of right atrial (RA) function, particularly RA peak longitudinal strain (LS), in transthyretin amyloid cardiomyopathy (ATTR-CM) remains unclear. This study aimed to investigate the relationship between RA function and AF onset in ATTR-CM.
methodsThe derivation cohort comprised 143 patients with ATTR-CM without prior atrial arrhythmias at Kumamoto University Hospital. Association between baseline parameters and new-onset AF during the follow-up period was analyzed using Cox regression models. Discrimination was assessed using time-dependent receiver operating characteristic analysis at 24 months.
resultsDuring follow-up (median, 30 months), 42 patients (29%) developed new-onset AF. Lower RA peak LS was independently associated with incident AF and showed moderate discrimination (time-dependent area under the curve, 0.72); the optimal cutoff at 24 months was 17.2%. Patients with RA peak LS <17.2% had significantly lower AF-free survival. A novel risk score integrating RA and left atrial peak LS and LA volume index effectively stratified AF risk. External validation in an independent cohort of 81 patients from Oita and Miyazaki University Hospitals confirmed consistent associations between lower RA peak LS and higher AF incidence, supporting the reproducibility of the findings.
conclusionsRA peak LS is a novel, robust predictor of new-onset AF in ATTR-CM and provides additional information alongside established clinical and left atrial parameters. Incorporating RA functional assessment may improve risk stratification and guide early interventions in high-risk patients.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Right Atrial Function as a Novel Predictor for New-Onset Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy. · full record | OpenQuestion